Search - tctmd.com

Displaying 301 - 320 of 4055

Sort: Relevancy | Date

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presentation TCT 2024

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presenter: Samit Shah

October 27, 2024

Considerations in Particulate Testing

Presentation TCT 2024

Considerations in Particulate Testing

Presenter: Samuel Raben

October 27, 2024

Considerations in Simulated Use Testing

Presentation TCT 2024

Considerations in Simulated Use Testing

Presenter: Kevin Soucy

October 27, 2024

TCT 1251: Adapting the Culotte: From Bench Testing to Complete Longitudinal Analysis of the First-in-Human Culotte Technique With Double Bioadaptors

Presentation TCT 2024

TCT 1251: Adapting the Culotte: From Bench Testing to Complete Longitudinal Analysis of the First-in-Human Culotte Technique With Double Bioadaptors

Presenter: Chin Wai Lai

October 27, 2024

Repeat Rejection Still a Problem After Pediatric Heart Transplant

News Daily News

Repeat Rejection Still a Problem After Pediatric Heart Transplant

October 23, 2024

What’s Going to Be Big at TCT 2024?

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

October 15, 2024

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

October 11, 2024

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

October 10, 2024

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

News Daily News

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

October 09, 2024

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

October 09, 2024

Incorrect Arm Positions Overestimate Blood Pressure Measurements

News Daily News

Incorrect Arm Positions Overestimate Blood Pressure Measurements

Michael O'Riordan

October 08, 2024

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

October 02, 2024

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

News Daily News

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

October 02, 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.